• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Biopsy examination of squamous cell carcinoma of the tongue: source of significant prognostic information?

作者信息

Moor J W, Wills S, Holzle F, Ong T K, Mitchell D A, MacLennan K A, Kanatas A N

机构信息

Department of Otolaryngology Head and Neck Surgery, Leeds General Infirmary, Great George Street, Leeds LS1 3EX, UK.

出版信息

Br J Oral Maxillofac Surg. 2010 Dec;48(8):594-7. doi: 10.1016/j.bjoms.2009.12.003. Epub 2009 Dec 31.

DOI:10.1016/j.bjoms.2009.12.003
PMID:20045230
Abstract

Histological analysis of tumour resection for squamous cell carcinoma (SCC) of the tongue yields prognostic information. We analysed histological slides of biopsy and tumour resection specimens using an adapted malignancy grading score and analysed variables of neck dissections. There was moderate correlation between biopsy and tumour resection using malignancy grading scores (correlation coefficient 0.45); good agreement of tumour grade (79%), tumour depth (76%), and type of invasive front (80%), but correlation was only fair to moderate (κ=0.38, κ=0.51, and κ=0.41, respectively). Correlation of the biopsy grading score and invaded nodes in the neck, extra capsular spread, and soft tissue disease was not significant.

摘要

相似文献

1
Biopsy examination of squamous cell carcinoma of the tongue: source of significant prognostic information?
Br J Oral Maxillofac Surg. 2010 Dec;48(8):594-7. doi: 10.1016/j.bjoms.2009.12.003. Epub 2009 Dec 31.
2
[Squamous-cell carcinoma of the tongue: treatment results and prognosis].[舌鳞状细胞癌:治疗结果与预后]
Rev Stomatol Chir Maxillofac. 2003 Feb;104(1):10-7.
3
[Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].[125例cT1-2N0期舌鳞状细胞癌患者术后复发相关因素分析]
Ai Zheng. 2007 Jun;26(6):661-5.
4
The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma.舌鳞状细胞癌深部浸润前沿组织学分级的高预后价值。
J Oral Pathol Med. 2005 Jul;34(6):329-33. doi: 10.1111/j.1600-0714.2005.00244.x.
5
Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients?舌前部癌及颈部淋巴结转移发生率随肿瘤厚度增加的情况:对所有患者进行颈部选择性治疗应成为标准做法吗?
ANZ J Surg. 2005 Mar;75(3):101-5. doi: 10.1111/j.1445-2197.2005.03306.x.
6
[Surgical management for occult cervical metastasis of oral tongue squamous cell carcinoma].[口腔舌鳞状细胞癌隐匿性颈淋巴结转移的外科治疗]
Ai Zheng. 2005 Mar;24(3):368-70.
7
Prognostic factors of clinically stage I and II oral tongue carcinoma-A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features.临床I期和II期口腔舌癌的预后因素——分期、厚度、形状、生长模式、浸润前沿恶性程度分级、马丁内斯-希门诺评分及病理特征的比较研究
Head Neck. 2002 Jun;24(6):513-20. doi: 10.1002/hed.10094.
8
[Survival analysis of 229 patients with advanced squamous cell carcinoma of the oral tongue].[229例晚期舌鳞状细胞癌患者的生存分析]
Ai Zheng. 2008 Dec;27(12):1315-20.
9
[Clinical and pathological related factors of occult cervical lymph node metastasis in squamous cell carcinoma of tongue].[舌鳞状细胞癌隐匿性颈淋巴结转移的临床及病理相关因素]
Ai Zheng. 2003 Jan;22(1):66-70.
10
[Relevant factors and management for patients with squamous carcinoma in tongue without clinical cervical lymphatic node metastasis].[舌鳞状细胞癌无临床颈淋巴结转移患者的相关因素及管理]
Zhonghua Kou Qiang Yi Xue Za Zhi. 2003 Jan;38(1):5-8.

引用本文的文献

1
Punch Biopsy for Preoperative Depth of Invasion Assessment in Early Oral Tongue Squamous Cell Carcinoma: A Prospective Pilot Study.用于早期口腔舌鳞状细胞癌术前浸润深度评估的打孔活检:一项前瞻性初步研究
J Otolaryngol Head Neck Surg. 2025 Jan-Dec;54:19160216251321452. doi: 10.1177/19160216251321452. Epub 2025 Apr 1.